June 6, 2019 Price forecast | 2 weeks: 3.30% | 1 month: 2.76% | 3 months: 3.78%


RCUS stock forecast

Our latest prediction for Arcus Biosciences, Inc.'s stock price was made on the June 6, 2019 when the stock price was at 7.99$.

In the short term (2weeks), RCUS's stock price should outperform the market by 3.30%. During that period the price should oscillate between -7.72% and +13.42%.

In the medium term (3months), RCUS's stock price should outperform the market by 3.78%. During that period the price should oscillate between -18.75% and +33.88%.

Create a solid portfolio with RCUS

Add RCUS to your portfolio and optimize it!


About Arcus Biosciences, Inc.

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

At the moment the company generates 9M USD in revenues.

On its last earning announcement, the company reported a loss of -1.47$ per share.

The book value per share is 5.73$

Arcus Biosciences, Inc. website


Three months stock forecastJune 6, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
9M - -74M -786.50% -69M -1.47 - - 43M 5.73 -55M -3M -58M